Asset Details
Do you wish to reserve the book?
Conformational dynamics and binding free energy analyses unveil a stable flavonoid inhibitor of dengue virus NS5 polymerase
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Conformational dynamics and binding free energy analyses unveil a stable flavonoid inhibitor of dengue virus NS5 polymerase
Do you wish to request the book?
Conformational dynamics and binding free energy analyses unveil a stable flavonoid inhibitor of dengue virus NS5 polymerase
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Conformational dynamics and binding free energy analyses unveil a stable flavonoid inhibitor of dengue virus NS5 polymerase
2026
Overview
The persistent global spread of dengue virus (DENV) necessitates the identification of novel antiviral therapeutics. The RNA-dependent RNA polymerase (RdRp) domain of the non-structural protein 5 (NS5) is a validated target for therapy due to its critical roles in viral genome replication. In this study, we used a structure-guided virtual screening approach to identify potent phytochemical inhibitors of DENV RdRp from the Plant Secondary Compound Database (PSC-db) by focusing on 326 flavonoids. Following drug-likeness filtering and hierarchical docking with MM-GBSA analysis, five top candidates were identified, with PSCdb01560 emerging as the most promising. Subsequent molecular dynamics simulations over 500 ns revealed PSCdb01560’s exceptional binding stability, characterised by low protein–ligand RMSD and sustained binding stability. Free energy landscape analysis demonstrated its occupation of deep, well-defined conformational basins. At the same time, post-MD MM-GBSA yielded a binding free energy of –91.65 kcal/mol—outperforming the reference compound. Structural superimposition confirmed strong conformational fidelity between docked and minimum-energy poses (RMSD 1.68 Å). Together, our approach points toward PSCdb01560 as the putative inhibitor molecule that outperforms existing flavonoid leads in thermodynamic and kinetic descriptors. The results thus provide the avenue for experimental validation, such as enzymatic and antiviral screens, in hopes of turning these in silico observations into viable therapeutic development for dengue.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/154
/ 631/45
/ 631/535
/ Antiviral Agents - chemistry
/ Antiviral Agents - pharmacology
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Humanities and Social Sciences
/ Ligands
/ Molecular Docking Simulation
/ Molecular Dynamics Simulation
/ Proteins
/ PSC-db
/ RdRp
/ RNA-Dependent RNA Polymerase - antagonists & inhibitors
/ RNA-Dependent RNA Polymerase - chemistry
/ RNA-Dependent RNA Polymerase - metabolism
/ Science
/ Viral Nonstructural Proteins - antagonists & inhibitors
